Technical Analysis for BDX - Becton, Dickinson and Company

Grade Last Price % Change Price Change
grade B 247.57 1.19% 2.90
BDX closed up 1.19 percent on Tuesday, March 19, 2019, on 1.33 times normal volume. It was able to find support at its 50 day moving average. It was able to bounce off of its 200 day moving average, an important long-term support line.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical BDX trend table...

Date Alert Name Type % Chg
Mar 19 200 DMA Support Bullish 0.00%
Mar 19 50 DMA Support Bullish 0.00%
Mar 19 Golden Cross Bullish 0.00%
Mar 19 Cup with Handle Other 0.00%
Mar 19 Bollinger Band Squeeze Range Contraction 0.00%
Mar 19 BB Squeeze + Lower Band Touch Range Contraction 0.00%
Mar 19 Inside Day Range Contraction 0.00%
Mar 19 Lower Bollinger Band Touch Weakness 0.00%
Mar 18 Fell Below 20 DMA Bearish 1.19%
Mar 18 New Downtrend Bearish 1.19%

Older signals for BDX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. This segment's products include needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles used in treatment of diabetes; prefillable drug delivery systems; anesthesia needles and trays; sharps disposal containers; and closed-system transfer devices. Its BD Diagnostics segment provides products for the collection and transport of diagnostics specimens; and instrument systems and reagents to detect various infectious diseases, healthcare-associated infections, and cancers. This segment's products comprise integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing systems; molecular testing systems; microorganism identification and drug susceptibility systems; liquid-based cytology systems; rapid diagnostic assays; microbiology laboratory automation; and plated media. The company's BD Biosciences segment offers research and clinical tools that facilitate the study of cells and their components. This segment's products include fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; cell imaging systems; laboratory products for tissue culture and fluid handling; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Medicine Biotechnology Biology Pharmaceutical Industry Infectious Diseases Diabetes Antibodies New Jersey Cancers Medical Technology Catheters Medical Devices Medical Tests Drug Delivery Healthcare Associated Infections Treatment Of Diabetes Healthcare Institutions Drug Delivery Systems Laboratory Products Syringe Becton Clinical Tools
Is BDX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 265.87
52 Week Low 208.62
Average Volume 1,012,156
200-Day Moving Average 243.031
50-Day Moving Average 243.4552
20-Day Moving Average 249.944
10-Day Moving Average 249.454
Average True Range 4.3813
ADX 27.76
+DI 26.1742
-DI 26.4807
Chandelier Exit (Long, 3 ATRs ) 244.0161
Chandelier Exit (Short, 3 ATRs ) 255.1839
Upper Bollinger Band 255.1036
Lower Bollinger Band 244.7844
Percent B (%b) 0.27
BandWidth 4.128605
MACD Line 1.4943
MACD Signal Line 2.2607
MACD Histogram -0.7664
Fundamentals Value
Market Cap 56.34 Billion
Num Shares 228 Million
EPS 3.45
Price-to-Earnings (P/E) Ratio 71.76
Price-to-Sales 3.93
Price-to-Book 3.79
PEG Ratio 2.05
Dividend 2.92
Dividend Yield 1.18%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 255.12
Resistance 3 (R3) 254.30 250.98 253.86
Resistance 2 (R2) 250.98 249.06 251.38 253.44
Resistance 1 (R1) 249.27 247.87 250.13 250.09 253.02
Pivot Point 245.95 245.95 246.37 246.35 245.95
Support 1 (S1) 244.24 244.03 245.10 245.06 242.12
Support 2 (S2) 240.92 242.84 241.32 241.70
Support 3 (S3) 239.21 240.92 241.28
Support 4 (S4) 240.03